Similar Papers

Paper Title
Journal
Date
Author
Plasma arginine as a candidate predictive biomarker for response to immune checkpoint inhibition (ICI) in metastatic colorectal cancer (mCRC): Analysis of the CCTG CO.26 trial.
...
Journal of Clinical Oncology | VOL. 41
, et. al. ...
01 Jun 2023
Overall Survival and Subgroup Analysis from a Randomized Phase III Study of Intravenous Rigosertib Versus Best Supportive Care (BSC) in Patients (pts) with Higher-Risk Myelodysplastic Syndrome (HR-MDS) after Failure of Hypomethylating Agents (HMAs)
...
Blood | VOL. 124
, et. al. ...
06 Dec 2014
PD-9 Three-arm phase II/III randomized controlled trial in patients with unresectable/metastatic gall bladder cancer with poor performance status: Erlotinib or capecitabine v/s best supportive care
B Kataria ... S Vishnubhatla
Annals of Oncology | VOL. 33
B Kataria, et. al.B Kataria ... S Vishnubhatla
01 Jun 2022
Low-Dose Decitabine Vs Best Supportive Care In Older Patients With AML and Low Blast Counts: Results Of a Subgroup Analysis Of The Randomized Phase III Study 06011 Of The EORTC Leukemia Cooperative Group and German MDS Study Group
Heiko Becker ... Carlo Aul
Blood | VOL. 122
Heiko Becker, et. al.Heiko Becker ... Carlo Aul
15 Nov 2013
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing
Janis M Taube ... Carlo B Bifulco
Journal for ImmunoTherapy of Cancer | VOL. 13
Janis M Taube, et. al.Janis M Taube ... Carlo B Bifulco
08 Jan 2025
Weal and woe of interleukin-18 in the T cell therapy of cancer
Christoph Kessel ... Hinrich Abken
Journal for ImmunoTherapy of Cancer | VOL. 13
Christoph Kessel, et. al.Christoph Kessel ... Hinrich Abken
01 Jan 2025
CD93 blockade promotes effector T-cell infiltration and facilitates adoptive cell therapy in solid tumors
Yi Sun ... Yuwen Zhu
Journal for ImmunoTherapy of Cancer | VOL. 13
Yi Sun, et. al.Yi Sun ... Yuwen Zhu
01 Jan 2025
Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma
Daniela Esposito ... Luigi Formisano
Journal for ImmunoTherapy of Cancer | VOL. 13
Daniela Esposito, et. al.Daniela Esposito ... Luigi Formisano
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.